Swiss National Bank Grows Stock Holdings in CorVel Co. (NASDAQ:CRVL)

Swiss National Bank lifted its position in CorVel Co. (NASDAQ:CRVL - Free Report) by 200.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,500 shares of the business services provider's stock after purchasing an additional 37,000 shares during the quarter. Swiss National Bank owned about 0.11% of CorVel worth $6,175,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of CRVL. Advisors Asset Management Inc. lifted its position in CorVel by 121.7% during the third quarter. Advisors Asset Management Inc. now owns 204 shares of the business services provider's stock valued at $67,000 after purchasing an additional 112 shares during the period. Intech Investment Management LLC purchased a new position in shares of CorVel during the 3rd quarter valued at about $2,797,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of CorVel by 7.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 86,236 shares of the business services provider's stock valued at $28,190,000 after buying an additional 6,061 shares during the period. Citigroup Inc. boosted its stake in shares of CorVel by 68.5% in the third quarter. Citigroup Inc. now owns 11,662 shares of the business services provider's stock worth $3,812,000 after buying an additional 4,742 shares during the last quarter. Finally, Cerity Partners LLC acquired a new stake in CorVel during the third quarter worth about $773,000. Institutional investors and hedge funds own 51.36% of the company's stock.

Insider Buying and Selling at CorVel

In other news, Director Steven J. Hamerslag sold 10,000 shares of CorVel stock in a transaction on Thursday, February 6th. The stock was sold at an average price of $123.48, for a total transaction of $1,234,800.00. Following the transaction, the director now owns 314,000 shares in the company, valued at $38,772,720. The trade was a 3.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Brandon O'brien sold 1,523 shares of CorVel stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the transaction, the chief financial officer now directly owns 17,142 shares in the company, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 32,200 shares of company stock valued at $3,824,115 over the last ninety days. Corporate insiders own 47.57% of the company's stock.

Remove Ads

CorVel Price Performance

CRVL stock traded up $0.42 during midday trading on Thursday, hitting $111.95. 91,119 shares of the stock traded hands, compared to its average volume of 106,321. CorVel Co. has a 1-year low of $76.20 and a 1-year high of $128.61. The stock's fifty day simple moving average is $112.14 and its 200-day simple moving average is $114.36. The firm has a market cap of $5.75 billion, a P/E ratio of 65.85 and a beta of 1.06.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analysts Set New Price Targets

Separately, StockNews.com downgraded CorVel from a "buy" rating to a "hold" rating in a report on Thursday, March 13th.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.